Regulates Romiplostim (rlNN, USAN) is a fusion protein analog of thrombopoietin, a hormone that regulates platelet production
Dose: weekly intervals via S.C. injection. Prior to injection, acomplete blood count (CBC) is obtained, as the Dosage is dependent on the individual's body weight and platelet count at the time of treatment. The goal of treatment is to maintain the count above 50,000 per cubic millimeter (mm3) of blood, not to achieve a normal count—defined as 150,000-450,000 per mm3 in most healthy individuals. If a count of 200,000 or higher is achieved for two consecutive weeks a reduced dose is administered or treatment is suspended until the count decreases below 200,000. Discontinuation of romiplostim must be approached with great caution, as a rapid decrease in the platelet count may occur, possibly leading to bleeding diathesis.
Vial
مرة واحدة يوميا
10716 EGP
Regulates Romiplostim (rlNN, USAN) is a fusion protein analog of thrombopoietin, a hormone that regulates platelet production
Dose: weekly intervals via S.C. injection. Prior to injection, acomplete blood count (CBC) is obtained, as the Dosage is dependent on the individual's body weight and platelet count at the time of treatment. The goal of treatment is to maintain the count above 50,000 per cubic millimeter (mm3) of blood, not to achieve a normal count—defined as 150,000-450,000 per mm3 in most healthy individuals. If a count of 200,000 or higher is achieved for two consecutive weeks a reduced dose is administered or treatment is suspended until the count decreases below 200,000. Discontinuation of romiplostim must be approached with great caution, as a rapid decrease in the platelet count may occur, possibly leading to bleeding diathesis.
Note: All the provided information about this drug does not substitute for consulting a doctor.